跳至主要内容
临床试验/NCT04223076
NCT04223076Unknown4 期

Clinical Performance of Two 0.2% Chlorhexidine Mouth Rinses After Periodontal Surgery. A Blinded, Intra-individual Cross-over Clinical Trial

University of Oslo1 个研究点 分布在 1 个国家目标入组 31 人开始时间: 2019年3月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
31
试验地点
1
主要终点
Plaque index

研究概览

简要总结

Chlorhexidine is the gold standard of dental plaque prevention. Recent research have demonstrated that 0.2% Chlorhexidine solutions are more effective than 0.12% and 0.06% Chlorhexidine solutions. Several 0.2% solutions are available on the market. This study aimed to compare effectiveness of two commercially available 0.2% chlorhexidine mouthwashes. Patients, that after initial periodontal therapy, had a need for two periodontal surgeries, will be invited to join. After one surgical session, the patient will receive one 0.2% chlorhexidine solution, and after the next surgical session the patient will receive the other 0.2% chlorhexidine solution. Plaque and gingivitis will be recorded, as well as side effects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Periodontitis, stage III and IV

排除标准

  • Uncontrolled diabetes Systemic conditions associated with excessive bleeding Uncontrolled hypertension

研究组 & 干预措施

Chlorhexidine 0.2% mouthwash control

Experimental

Chlorhexidine 0.2%, Corsodyl Intervention rinsing 60 sec twice daily

干预措施: Chlorhexidine 0.2%, Corsodyl (Drug)

Chlorhexidine 0.2% mouthwash with an Anti Discoloring System

Experimental

Chlorhexidine 0.2%, Curasept Intervention rinsing 60 sec twice daily

干预措施: Chlorhexidine 0.2%, Curasept (Drug)

结局指标

主要结局

Plaque index

时间窗: 14 days intervention period

Dental Plaque

Gingival Index

时间窗: 14 days intervention period

Gingivitis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Erik Mauland

DDS

University of Oslo

研究点 (1)

Loading locations...

相似试验